指纹测定大脑中异细胞β-上腺受体的功能表达,使用激进分子活动概况
Rachel A Matt1, Frederick G Westhorpe1, Rosemary F Romuar1
1Department of Pharmacology, CuraSen Therapeutics, San Carlos, CA, United States.
Frontiers in molecular biosciences
|September 4, 2023
概括
这项研究揭示了人类大脑细胞中的功能β-2上腺受体 (β2-AR) 表达,这对唤醒和记忆很重要. 这一发现为神经退行性疾病的治疗提供了洞察力,这些疾病会影响心脏部位.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 来自座的诺拉德仁基通路调节关键大脑功能,如唤醒,注意力,情绪和记忆.
- 不同上腺受体 (AR) 在不同类型的大脑细胞中的特定作用尚未完全理解,特别是关于激素活性.
- 了解AR功能对于开发神经退行性疾病的治疗方法至关重要,这些疾病与神经节位 (locus coeruleus) 衰退有关.
研究的目的:
- 在药理上描述大脑上腺受体 (AR) 功能,使用新的激素激剂活性指标.
- 评估人类大脑细胞系统中的β-adrenoceptor (β-AR) 亚型表达和潜在的连接物偏差.
- 提供针对神经退行性疾病中诺亚上能通路的治疗干预措施的见解.
主要方法:
- 测量了重组细胞系统中的β-AR主激素活性,并将其与异上腺素进行比较,以获得系统独立的Δlog(Emax/EC50) 值.
- 使用 Δlog(Emax/EC50) 值作为受体亚型指纹来评估人类大脑细胞系统中的表达.
- 研究了β-arrestin激活和cAMP反应脱敏化,以评估β-AR激动剂中潜在的连接物偏差.
主要成果:
- 证实 Δlog(Emax/EC50) 激素活性概况是独立于系统的,作为可靠的受体指纹.
- 在多种人类大脑细胞类型中证明了功能性β2-上腺受体 (β2-AR) 表达.
- 在检查的系统中,没有发现对测试的β-AR激动剂有关同源受体脱敏化的连接体偏差的证据.
结论:
- 功能性β2-AR表达在不同的人类大脑细胞中,支持locus coeruleus noradrenergic调在神经兴奋和恒温中发挥的作用.
- Δlog(Emax/EC50) 激进分子指纹检测方法是评估受体亚型表达的强有力的工具.
- 这种方法可以应用于研究各种组织中的新联体和受体,有助于发现神经系统疾病的药物.
相关概念视频
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
918
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
918
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K


